Open Access
bai.chunxue@ zs-hospital.sh.cnYANG Dawei, M.D., Ph.D., Associate Chief Physician, Associate Research Fellow, E-mail: yang.dawei@zs-hospital.sh.cn
Corresponding author: BAI Chunxue, M.D., Ph.D., Professor, Tel: +86-21-64041990, E-mail: bai.chunxue@zs-hospital.sh.cn
Supported by Fund of Noncommunicable Chronic Diseases-National Science and Technology Major Project(2024ZD0529300)and Science and Technology Commission of Shanghai Municipality(20DZ2254400,21DZ2200600).
Open Access
bai.chunxue@ zs-hospital.sh.cnYANG Dawei, M.D., Ph.D., Associate Chief Physician, Associate Research Fellow, E-mail: yang.dawei@zs-hospital.sh.cn
Corresponding author: BAI Chunxue, M.D., Ph.D., Professor, Tel: +86-21-64041990, E-mail: bai.chunxue@zs-hospital.sh.cn
Supported by Fund of Noncommunicable Chronic Diseases-National Science and Technology Major Project(2024ZD0529300)and Science and Technology Commission of Shanghai Municipality(20DZ2254400,21DZ2200600).
This study aims to compare the clinical value of a general large language model (DeepSeek GPT) and a disease-specific optimized model (BAIMGPT) in pulmonary nodule consultation and management. Through a multicenter real-world study, 1,000 patients with pulmonary nodules from 12 hospitals will be recruited for a randomized self-controlled trial evaluating the performance of the two models across eight dimensions: convenience, friendliness, sense of security, accuracy in question comprehension, response professionalism, voice interaction, visual empowerment, and demand level. The core methodologies include dual user evaluation, third-party blinded review, and endpoint assessment. The study was expected to validate BAIMGPT’s advantages in improving screening awareness, personalized management, and physician-patient trust, providing evidence-based support for AIpowered early lung cancer screening. The protocol has passed ethical review, with anonymized data processing ensuring both innovation and safety.
Key Words: plmonary nodule; BAIMGPT; DeepSeek GPT
ISSN: 3006-4236
Volume 2, Issue 3
September 2025
Pages: 1-64